# Etodolac and Post-bleaching Sensitivity

> **NCT02881619** · PHASE4 · COMPLETED · sponsor: **Flavia Pardo Salata Nahsan** · enrollment: 50 (actual)

## Conditions studied

- Medicaments Substances in Therapeutic Use

## Interventions

- **DRUG:** Etodolac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02881619
- **Lead sponsor:** Flavia Pardo Salata Nahsan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02881619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02881619, "Etodolac and Post-bleaching Sensitivity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02881619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*